{"id":6418,"date":"2022-04-05T15:17:39","date_gmt":"2022-04-05T15:17:39","guid":{"rendered":"https:\/\/wilate.com\/ca\/?page_id=6418"},"modified":"2023-01-24T13:06:30","modified_gmt":"2023-01-24T13:06:30","slug":"clinical-trials","status":"publish","type":"page","link":"https:\/\/wilate.com\/ca\/clinical-trials\/","title":{"rendered":"Clinical trials"},"content":{"rendered":"<h1>Clinical trials<\/h1>\n<p><strong>At Octapharma, we are committed to better understanding von Willebrand disease and to improving the care of people with this condition.<\/strong><\/p>\n<p><strong><br \/><\/strong>Over 15 years of clinical and real-life experience have already proven the efficacy and tolerability of wilate<sup>\u00ae<\/sup> in people with all types of von Willebrand disease for surgery, prophylaxis and on-demand treatment.<sup>1-3<\/sup> However, there is still more to learn. We continue to work with the scientific and clinical community to improve our understanding of von Willebrand disease, and are proud to support numerous clinical trials and investigator-initiated studies.<\/p>\n<h2>Published clinical trials with wilate<sup>\u00ae<\/sup><\/h2>\n<h2>in people with von Willebrand disease<\/h2>\n<h2>Wilate Clinical Development Program in<br \/>von Willebrand disease<\/h2>\n<p>As part of Octapharma\u2019s long-standing commitment to addressing the unmet clinical needs of people with von Willebrand disease, Octapharma continues to carry out clinical trials to better understand the clinical efficacy and safety of wilate<sup>\u00ae<\/sup> in different patient populations<\/p>\n<p>Link to the trial on clinicaltrials.gov<\/p>\n<p><a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04146376\" target=\"_blank\" rel=\"noopener\">VIP-study<\/a><\/p>\n<h2>Octapharma Initiated Phase 4 Studies<\/h2>\n<p>Links to the respective trials on clinicaltrials.gov<\/p>\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04953884\" target=\"_blank\" rel=\"noopener\">WIL-33<\/a>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04052698\" target=\"_blank\" rel=\"noopener\">WIL-31<\/a><\/p>\n<h2>Investigator-initiated studies<\/h2>\n<p><a href=\"https:\/\/vipstudy.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2023\/01\/vip-1024x210.webp\" alt=\"\" width=\"800\" height=\"164\" \/><\/a><\/p>\n<p>\u00a0<\/p>\n<p>The von Willebrand factor in pregnancy (VIP) study is a prospective, multicentre, investigator-initiated study aiming to increase our understanding of postpartum bleeding in women with von Willebrand disease.<\/p>\n<p>For more details, visit<br \/><a href=\"https:\/\/vipstudy.com\/\" target=\"_blank\" rel=\"noopener\">vipstudy.com<\/a> or <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04146376\" target=\"_blank\" rel=\"noopener\">clinicaltrials.gov<\/a><\/p>\n<h6>Principal Investigators<br \/><\/h6>\n<h6>Jill M. Johnsen MD<\/h6>\n<h6>Bloodworks, Seattle, WA, USA<\/h6>\n<h6>Barbara A. Konkle MD<\/h6>\n<h6>Bloodworks, Seattle, WA, USA<\/h6>\n<h6>Peter A. Kouides MD<\/h6>\n<h6>Mary M. Gooley Hemophilia Center, Rochester, NY, USA<\/h6>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2023\/01\/empower-1024x210.webp\" alt=\"\" width=\"800\" height=\"164\" \/><\/p>\n<p>&nbsp;<\/p>\n<p style=\"padding-top: 25px;\">A multi-cEntre pilot crossover trial of prophylactic wilate<sup>\u00ae<\/sup> coMpared to PlacebO for heavy menstrual bleeding in patients with low von WillEbrand factoR and von Willebrand disease (EMPOWER)<\/p>\n<h6>Principal Investigators<\/h6>\n<h6>Michelle Sholzberg MDCM<\/h6>\n<h6>University of Toronto, Canada<\/h6>\n<h4>References<\/h4>\n<ol>\n<li>Srivastava A et al. <em>Haemophilia<\/em> 2017; 23:264-72.<\/li>\n<li>Windyga J and von Depka-Prondzinski M. <em>Thromb Haemost<\/em> 2011; 105:1072-79.<\/li>\n<li>Berntorp E and Windyga J. <em>Haemophilia<\/em> 2009; 15:122-30.<\/li>\n<li>Nowak-G\u00f6ttl U et al. <em>Haemophilia<\/em> 2013; 19:887-92.<\/li>\n<li>Batty P et al. <em>Haemophilia<\/em> 2014; 20: 846-53.<\/li>\n<li>Khair K et al. <em>Haemophilia<\/em> 2015; 21:e44-50.<\/li>\n<li>Sholzberg M et al. <em>TH Open<\/em> 2021; 5:e264-72.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Clinical trials At Octapharma, we are committed to better understanding von Willebrand disease and to improving the care of people with this condition. Over 15 years of clinical and real-life experience have already proven the efficacy and tolerability of wilate\u00ae in people with all types of von Willebrand disease for surgery, prophylaxis and on-demand treatment.1-3 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-6418","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical trial data in von willebrand disease<\/title>\n<meta name=\"description\" content=\"Building on 15 years of clinical trials and real-life experience that support efficacy and safety, research continues.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wilate.com\/ca\/clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical trial data in von willebrand disease\" \/>\n<meta property=\"og:description\" content=\"Building on 15 years of clinical trials and real-life experience that support efficacy and safety, research continues.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wilate.com\/ca\/clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"WILATE CA\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-24T13:06:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2023\/01\/vip-1024x210.webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/\",\"url\":\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/\",\"name\":\"Clinical trial data in von willebrand disease\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/wilate.com\\\/ca\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2023\\\/01\\\/vip-1024x210.webp\",\"datePublished\":\"2022-04-05T15:17:39+00:00\",\"dateModified\":\"2023-01-24T13:06:30+00:00\",\"description\":\"Building on 15 years of clinical trials and real-life experience that support efficacy and safety, research continues.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/wilate.com\\\/ca\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2023\\\/01\\\/vip-1024x210.webp\",\"contentUrl\":\"https:\\\/\\\/wilate.com\\\/ca\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2023\\\/01\\\/vip-1024x210.webp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/wilate.com\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/wilate.com\\\/ca\\\/\",\"name\":\"WILATE CA\",\"description\":\"Putting you in control of von Willebrand disease\",\"publisher\":{\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/wilate.com\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/#organization\",\"name\":\"WILATE CA\",\"url\":\"https:\\\/\\\/wilate.com\\\/ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/wilate.com\\\/ca\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/03\\\/Wilate-logo-untertitel@2x-padding.png\",\"contentUrl\":\"https:\\\/\\\/wilate.com\\\/ca\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/03\\\/Wilate-logo-untertitel@2x-padding.png\",\"width\":504,\"height\":202,\"caption\":\"WILATE CA\"},\"image\":{\"@id\":\"https:\\\/\\\/wilate.com\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical trial data in von willebrand disease","description":"Building on 15 years of clinical trials and real-life experience that support efficacy and safety, research continues.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wilate.com\/ca\/clinical-trials\/","og_locale":"en_GB","og_type":"article","og_title":"Clinical trial data in von willebrand disease","og_description":"Building on 15 years of clinical trials and real-life experience that support efficacy and safety, research continues.","og_url":"https:\/\/wilate.com\/ca\/clinical-trials\/","og_site_name":"WILATE CA","article_modified_time":"2023-01-24T13:06:30+00:00","og_image":[{"url":"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2023\/01\/vip-1024x210.webp","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/wilate.com\/ca\/clinical-trials\/","url":"https:\/\/wilate.com\/ca\/clinical-trials\/","name":"Clinical trial data in von willebrand disease","isPartOf":{"@id":"https:\/\/wilate.com\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wilate.com\/ca\/clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/wilate.com\/ca\/clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2023\/01\/vip-1024x210.webp","datePublished":"2022-04-05T15:17:39+00:00","dateModified":"2023-01-24T13:06:30+00:00","description":"Building on 15 years of clinical trials and real-life experience that support efficacy and safety, research continues.","breadcrumb":{"@id":"https:\/\/wilate.com\/ca\/clinical-trials\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wilate.com\/ca\/clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/wilate.com\/ca\/clinical-trials\/#primaryimage","url":"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2023\/01\/vip-1024x210.webp","contentUrl":"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2023\/01\/vip-1024x210.webp"},{"@type":"BreadcrumbList","@id":"https:\/\/wilate.com\/ca\/clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/wilate.com\/ca\/"},{"@type":"ListItem","position":2,"name":"Clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/wilate.com\/ca\/#website","url":"https:\/\/wilate.com\/ca\/","name":"WILATE CA","description":"Putting you in control of von Willebrand disease","publisher":{"@id":"https:\/\/wilate.com\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wilate.com\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/wilate.com\/ca\/#organization","name":"WILATE CA","url":"https:\/\/wilate.com\/ca\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/wilate.com\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2022\/03\/Wilate-logo-untertitel@2x-padding.png","contentUrl":"https:\/\/wilate.com\/ca\/wp-content\/uploads\/sites\/5\/2022\/03\/Wilate-logo-untertitel@2x-padding.png","width":504,"height":202,"caption":"WILATE CA"},"image":{"@id":"https:\/\/wilate.com\/ca\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/pages\/6418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/comments?post=6418"}],"version-history":[{"count":774,"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/pages\/6418\/revisions"}],"predecessor-version":[{"id":12920,"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/pages\/6418\/revisions\/12920"}],"wp:attachment":[{"href":"https:\/\/wilate.com\/ca\/wp-json\/wp\/v2\/media?parent=6418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}